Peritoneal dialysis-related peritonitis treatment recommendations: 1996 update

Peritoneal Dialysis International

Volumn 16, Issue 6, 1996, Pages 557-573

  Keane, William F ^a,n   Alexander, Steven R ^b   Bailie, George R ^c   Boeschoten, Elizabeth ^d   Gokal, Raman ^e   Golper, Thomas A ^f   Holmes, Clifford J ^g   Huang, Chiu Ching ^h   Kawaguchi, Yoshindo ⁱ   Piraino, Beth ^j   Riella, Miguel ^k   Schaefer, Franz ^l   Vas, Stephen ^m  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c ALBANY COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^f UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^g BAXTER HEALTHCARE CORPORATION   (United States)

^h CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

ⁱ JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^j UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^k Evangelic School of Medicine   (Brazil)

^l UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^m UNIVERSITY HEALTH NETWORK   (Canada)

ⁿ HENNEPIN COUNTY MEDICAL CENTER   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PERITONEAL DIALYSIS; PERITONITIS; RECURRENT DISEASE;

ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; PERITONEAL DIALYSIS; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; PERITONITIS; RECURRENCE;

EID: 0030279931     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089601600606     Document Type: Review

References (45)

1. Bailie GR, Eisele G. Pharmacokinetic issues in the treatment of CAPD peritonitis. J Antimicrob Chemother 1995; 35:563-7.
2. Barza M, Ioannidis JPA, Cappelleri JC, Lau J. Single or multiple daily doses of aminoglycosides: a metaanalysis. BMJ 1996; 312:338-45.
3. Bernardini J, Piraino B, Holley J, Johnston JR, Lutes R. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin. Am J Kidney Dis 1996; 27:695-700.
4. Bunke M, Brier ME, Golper TA. Culture-negative CAPD peritonitis: the network 9 study. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1994; 10:174-8.
5. Buring JE, Evans DA, Mayrent SL, Rosner B, Colton T, Hennekens CH. Randomized trials of aminoglycoside antibiotics: quantitative overview. Rev Infect Dis 1988; 10(5):951.
6. Chan MK, Chan PCK, Cheng IPK, et al. Pseudomonas peritonitis in CAPD patients: characteristics and outcome of treatment. Nephrol Dial Transplant 1989; 4:814-17.
7. Cheng IKP, Fang GX, Chan TM, et al. Fungal peritonitis complicating peritoneal dialysis: report of 27 cases and review of treatment. Q J Med 1989; 71:407-16.
8. Churchill DN, Taylor DW, Vas SI, et al. Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): a multi-centre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Perit Dial Int 1989; 9:159-63.
9. Coles GA, for the Mupirocin Study Group. The effect of intranasal mupirocin on CAPD exit site infection (ESI). J Am Sac Nephrol 1994; 5:439.
10. Working Party of the British Society for Antimicrobial Chemotherapy. Diagnosis and management of peritonitis in continuous ambulatory peritoneal dialysis. Lancet 1987; i:845-8.
11. Eisenberg ES, Leviton I, Sociro R. Fungal peritonitis in patients receiving peritoneal dialysis: experience with 11 patients and review of the literature. Rev Infect Dis 1986; 8:309-21.
12. Fine RN, Salusky IB, Hall T, Lucullo L, Jordan SC, Ettenger RB. Peritonitis in children undergoing continuous ambulatory peritoneal dialysis. Pediatrics 1983; 71:806-9.
13. Flanigan MJ, Hochstetler LA, Langholdt D, Lim VS. Continuous ambulatory peritoneal dialysis catheter infections: diagnosis and management. Perit Dial Int 1994; 14:248-54.
14. Gilbert DN. Once-daily aminoglycoside therapy. Antimicrob Agents Chemother 1991; 399-405.
15. Govaerts PJ, Claes J, Van De Heyning PH, Jorens PG, Marquet J, De Broe ME. Aminoglycoside-induced ototoxicity. Toxicol Lett 1990; 52:227-51.
16. Innes A, Burden RP, Finch RG, Morgan AG. Treatment of resistant peritonitis in continuous ambulatory peritoneal dialysis with intraperitoneal urokinase: a double blind trial. Nephrol Dial Transplant 1994; 9:797-9.
17. Klaus G, Schaefer F, Müller-Wiefel D, Mehls O, for the Arbeitgemeinschaft Pädiatrische Nephrologie. Treatment of peritoneal dialysis-associated peritonitis with continuous versus intermittent vancomycin/teicoplanin and ceftazidime in children: preliminary results of a prospective randomized trial. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications Inc., 1995; 11:296-301.
18. Kuizon B, Melocoton TL, Holloway M, et al. Infectious and catheter-related complications in pediatric patients treated with peritoneal dialysis at a single institution.Pediatr Nephrol 1995; 9(Suppl):S12-17.
19. Lomaestro BM, Bailie GR. Absorption interactions with fluoroquinolones: 1995 update Drug Saf 1995; 12:314-37.
20. Low CL, Bailie GR, Evans A, Eisele G, Venezia RA. Pharmacokinetics of once-daily ip gentamicin in CAPD patients. Perit Dial Int 1996; (in press).
21. Lum GM. Peritonitis in infants and children on CAPD/CCPD. In: Anderiotti VE, Fine RN, eds. Topics in renal medicine. Vol. 4. Chronic ambulatory peritoneal dialysis (CAPD) and chronic cycling peritoneal dialysis (CCPD) in children. Amsterdam: Martinius Nijhoff; 1987:189-200.
22. Luzar MA, Brown CB, Balf D, et al. Exit site care and exit site infection in CAPD: results of a randomized multicenter trial. Perit Dial Int 1990; 10:25-9.
23. Millikin SP, Matzke GR, Keane WF. Antimicrobial treatment of peritonitis associated with continuous ambulatory peritoneal dialysis. Perit Dial Int 1991; 11:252-60.
24. Mion C, Slingeneyer A, Canaud B. Peritonitis. In: Gokal R, ed. Continuous ambulatory peritoneal dialysis. New York: Churchill Livingstone, 1986:163-217.
25. Nankivell BJ, Lake N, Gillies A. Intracatheter streptokinase for recurrent peritonitis in CAPD. Clin Nephrol 1991; 35:20-3.
26. Nolph KD, ed. Peritoneal dialysis. Dordrecht: Nijhoff Publishers; 1988.
27. Nolph KD, Lindblad AS, Novak JW. Continuous ambulatory peritoneal dialysis. N Engl J Med 1988; 318:1595-600.
28. Pagniez D, MacNamara E, Fortin F,et al. Withdrawal of continuous ambulatory peritoneal dialysis to treat mild peritonitis. BMJ 1988; 297:1174-5.
29. Peterson PK, Matzke GR, Keane WF. Current concepts in the management of peritonitis in continuous ambulatory peritoneal dialysis patients. Rev Infect Dis 1987; 9:604-12.
30. Piraino B, Bernardini J, Sorkin M. A five-year study of the microbiologic results of exit-site infections and peritonitis in continuous ambulatory peritoneal dialysis. Am J Kidney Dis 1987; 10:281-6.
31. Prins JM, Büller HR, Kuijper E, Tange RA, Speelman P. Once-daily gentamicin versus once-daily netilmicin in patients with serious infections - a randomized clinical trial. J Antimicrob Chemother 1994; 33:823-35.
32. Rubin J, Rogers WA, Taylor HM, et al. Peritonitis during continuous ambulatory peritoneal dialysis. Ann Intern Med 1980; 92:7-13.
33. Sewell DL, Golper TA, Hulman PB,et al. Comparison of large volume culture to other methods for isolation of microorganisms from dialysate. Perit Dial Int 1990; 10:49-52.
34. Spencer RC. Infections in continuous ambulatory peritoneal dialysis. J Med Microbiol 1988; 27:1-9.
35. Swartz R, Messana J, Reynolds J, Ranjit U. Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.Kidney Int 1991; 40:1160-5.
36. Tranaeus A, Heimburger O, Lindhohn B. Peritonitis during continuous ambulatory peritoneal dialysis (CAPD): risk factors, clinical severity, and pathogenetic aspects. Pent Dial Int 1988; 8:253-63.
37. Vas SI. Microbiologic aspects of chronic ambulatory peritoneal dialysis. Kidney Int 1983; 23:83-92.
38. Vas SI. Peritonitis. In: Gokal R, Nolph KD, eds. The textbook of peritoneal dialysis. 4th ed. Dordrecht: Kluwer Academic Publishers, 1994:473-501.
39. Vas SI. Renaissance of tuberculosis in the 1990s: lesson for the nephrologist. Perit Dial Int 1994; 14:209-14.
40. Warady BA, Campoy SF, Gross SP, Sedman AB, Lum GM. Peritonitis with continuous ambulatory peritoneal dialysis and continuous cycling peritoneal dialysis. J Pediatr 1984; 105:726-30.
41. Warady BA, Sullivan EK, Alexander SR. Lessons from the peritoneal dialysis patient data base: a report of the North American Pediatric Renal Transplant. Cooperative Study. Kidney Int 1996; 49(Suppl 53):S68-71.
42. Watson AR, Vigneaux A, Bannatyne RM, Balfe JW. Peritonitis during continuous ambulatory peritoneal dialysis in children. Can Med Assoc J 1986; 134:1019-22.
43. Williams AJ, Boeltis I, Johnson BF, et al. Tenckhoff catheter replacement or intraperitoneal urokinase: a randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis. Perit Dial Int 1989; 9:65-7.
44. Zäruba K, Peters J, Jungbluth H. Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: six years' experience. Am J Kidney Dis 1991; 17:43-6.
45. Zimmerman SW, Ahrens E, Johnson CA, et al. Randomized controlled trial of prophylactic rifampin for peritoneal dialysis related infections. Am J Kidney Dis 1991; 18:225-31.